Live Breaking News & Updates on Dysfunction Market|Page 2

Stay updated with breaking news from Dysfunction market. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Erectile Dysfunction Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Space


Erectile Dysfunction Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Space
iCrowd Newswire
DelveInsight s
Erectile Dysfunction market report overview of pathophysiology, various diagnostic approaches, and treatment algorithm, including detailed chapters for marketed products and emerging therapies
DelveInsight s
Some of the key highlights from the
A more extensive national study, the National Health and Social Life Survey, looked at sexual function surveyed 1,410 men aged 18 to 59 and documented an increase in ED with age.
Additionally, the study found a decrease in sexual desire with increasing age. Men in the oldest cohort (50 to 59) were more than three times as likely to experience erection problems and report low sexual desire as men 18 to 29. ....

United States , United Kingdom , Shruti Thakur , Stendram Stendra , Eli Lily , Cialis Eli Lily , National Health , Adamis Pharmaceuticals Corporation , Levitra Bayer Pharmaceuticals Corporation , Market Research , See Campaign , Research Newswire , Novartis Pharmaceuticals , Urovant Sciences , Bayer Pharmaceuticals Corporation , Erectile Dysfunction , Dysfunction Market , Social Life Survey , Futura Medical , Erectile Dysfunction Market , Treatable Cases , Specific Prevalent Cases , Erectile Dysfunction Epidemiology , Dysfunction Key Questions Answered , Intelligence Analysis , Market Overview ,

Erectile Dysfunction Market Size to Reach Revenues of USD 4.7 Billion by 2026


Erectile Dysfunction Market Size to Reach Revenues of USD 4.7 Billion by 2026 - Arizton
- In-depth analysis and data-driven insights on the impact of COVID-19 included in this global erectile dysfunction market report
CHICAGO, Feb. 9, 2021 /PRNewswire/ The global erectile dysfunction market is expected to retract at a CAGR of around (0.4%) during the period 2020-2026.
Key Highlights Offered in the Report:
ED is the most prevalent male sexual disorder globally. Multiple therapeutic and device treatment modalities are currently available for the management of the disease. However, the market is likely to witness a negative growth rate of around (-0.4%) due to drastic decline in revenues of popular branded drugs such as Viagra and Cialis. ....

United States , South Africa , Saudi Arabia , South Korea , Minas Gerais , Owen Mumford , Kostenloser Wertpapierhandel , Dornier Medtech , Aurobindo Pharma , Eli Lilly , Zimmer Medizinsysteme , Direx Group , Metuchen Pharmaceuticals , Guangzhou Pharmaceutical Holdings , Donga Socio Holdings , Menarini Group , Alembic Pharmaceuticals , Top Quality Group , Ferring Pharmaceuticals , Boston Scientific , Teva Pharmaceuticals , Eurology Health , Endo International , Route Of Administration , Highlights Offered , Dysfunction Market ,